Pharmaceutical composition for prevention of diet induced obesity
AssigneeFrimline Private Limited
InventorsAnkit Shyam Singh, Vedprakash Mishra, Neelima Tongra
Life of this patent
Estimating the term…
Abstract
The present invention relates to a pharmaceutical composition/formulation for the prevention of diet induced obesity. More particularly, the invention relates to a composition/formulation comprising a synergistic combination of Oleoylethanolamide (OEA) and other natural ingredients can be used for treatment of obesity and its related disorders associated with fat metabolism like non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD). This can also be helpful in controlling obesity by way of maintaining body weight. The invention also provides various formulations and methods of preparing the same.
Claims17
A pharmaceutical composition comprising a combination of Oleoylethanolamide (OEA) and natural ingredients, wherein the natural ingredients are selected from a naturally occurring β-aminoisobutyric acid (BAIBA), a natural anti-oxidant or a combination thereof.
Dependencies are inferred from the claim text.